Objectives: To investigate the importance of the side of clinical findings in predicting the
prognosis in multiple sclerosis (MS) patients. Methods: In our study we enrolled 361 MS …

With great interest, I have read the data published recently by Varoglu and Balkuv. 1 They
raised an interesting clinical question about the outcome and lateralization of clinical …

Background The clinical course of multiple sclerosis (MS) evolves over many years. Its
prognosis is highly variable among affected individuals, ie while some suffer from early …

Background: Specification of prognostic factors in multiple sclerosis (MS) is crucial for
clinicians to guide therapeutic protocols. This study aimed to identify demographic, clinical …

Objective: To explore the factors influencing the degree of disability in patients with multiple
sclerosis (MS), and to provide evidence for its early diagnosis, prognostic evaluation and …

Background: Polysymptomatic or monosymptomatic patients of multiple sclerosis (MS) at the
onset of the disease may influence the natural course of the disease. The purpose of this …

Background: Multiple sclerosis is an autoimmune neurodegenerative disease of central
nervous system characterized by inflammation, demyelination, as well as neuro …

Purpose: This study investigated the long-term clinical and demographic characteristics of
multiple sclerosis (MS) patients to predict disease prognosis. Materials and Methods: Two …

Background/Objective (s) Diagnosing secondary progressive multiple sclerosis (SPMS)
requires careful examination of the gradual decline that occurs following an initial relapsing …

Background: To assess disease progression in multiple sclerosis (MS) several outcome
measures are available. The interrelation of changes on different scales has not been …